TY  - JOUR
AU  - Moreno Gordaliza, María Estefanía
AU  - González Nicolás González, María Ángeles
AU  - Lázaro Fernández, Alberto
AU  - Barbas, C.
AU  - Gómez Gómez, María Milagros
AU  - López-Gonzálvez, A.
PY  - 2024
DO  - 10.1016/j.bcp.2024.116435
UR  - https://hdl.handle.net/20.500.14352/107086
T2  - Biochemical Pharmacology
AB  - Acute kidney injury (AKI) is one of the most serious complications of cisplatin anticancer therapies. Cilastatin is a highly promising nephroprotective agent to eventually enter clinical use, but its biochemical mechanism is still not fully...
LA  - eng
PB  - Elsevier
KW  - Cisplatin
KW  - Cilastatin
KW  - Nephrotoxicity
KW  - Nephroprotection
KW  - Metabolomics
KW  - Biomarkers
TI  - Untargeted metabolomics analysis of serum and urine unveils the protective effect of cilastatin on altered metabolic pathways during cisplatin-induced acute kidney injury
TY  - journal article
VL  - 227
ER  -